EXOSENS SAS (EXENS.PA) Fundamental Analysis & Valuation

EPA:EXENS • FR001400Q9V2

Current stock price

62.85 EUR
+1.95 (+3.2%)
Last:

This EXENS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. EXENS.PA Profitability Analysis

1.1 Basic Checks

  • In the past year EXENS was profitable.
  • EXENS had a positive operating cash flow in the past year.
  • Of the past 5 years EXENS 4 years were profitable.
  • Each year in the past 5 years EXENS had a positive operating cash flow.
EXENS.PA Yearly Net Income VS EBIT VS OCF VS FCFEXENS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 4.86%, EXENS is in the better half of the industry, outperforming 66.10% of the companies in the same industry.
  • EXENS has a Return On Equity of 9.58%. This is comparable to the rest of the industry: EXENS outperforms 42.37% of its industry peers.
  • EXENS's Return On Invested Capital of 10.78% is fine compared to the rest of the industry. EXENS outperforms 69.49% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for EXENS is in line with the industry average of 9.98%.
  • The 3 year average ROIC (8.65%) for EXENS is below the current ROIC(10.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.86%
ROE 9.58%
ROIC 10.78%
ROA(3y)3.81%
ROA(5y)-3.76%
ROE(3y)8.68%
ROE(5y)-10.88%
ROIC(3y)8.65%
ROIC(5y)N/A
EXENS.PA Yearly ROA, ROE, ROICEXENS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • EXENS has a Profit Margin of 9.12%. This is in the better half of the industry: EXENS outperforms 76.27% of its industry peers.
  • EXENS's Profit Margin has improved in the last couple of years.
  • EXENS has a better Operating Margin (22.85%) than 93.22% of its industry peers.
  • In the last couple of years the Operating Margin of EXENS has grown nicely.
  • EXENS's Gross Margin of 74.69% is amongst the best of the industry. EXENS outperforms 98.31% of its industry peers.
  • In the last couple of years the Gross Margin of EXENS has remained more or less at the same level.
Industry RankSector Rank
OM 22.85%
PM (TTM) 9.12%
GM 74.69%
OM growth 3Y16.35%
OM growth 5YN/A
PM growth 3Y17.77%
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5YN/A
EXENS.PA Yearly Profit, Operating, Gross MarginsEXENS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. EXENS.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EXENS is creating some value.
  • EXENS has a better debt/assets ratio than last year.
EXENS.PA Yearly Shares OutstandingEXENS.PA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 100M 200M 300M
EXENS.PA Yearly Total Debt VS Total AssetsEXENS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • EXENS has an Altman-Z score of 5.58. This indicates that EXENS is financially healthy and has little risk of bankruptcy at the moment.
  • EXENS has a better Altman-Z score (5.58) than 91.53% of its industry peers.
  • EXENS has a debt to FCF ratio of 4.65. This is a neutral value as EXENS would need 4.65 years to pay back of all of its debts.
  • EXENS's Debt to FCF ratio of 4.65 is in line compared to the rest of the industry. EXENS outperforms 55.93% of its industry peers.
  • A Debt/Equity ratio of 0.59 indicates that EXENS is somewhat dependend on debt financing.
  • EXENS has a Debt to Equity ratio of 0.59. This is comparable to the rest of the industry: EXENS outperforms 40.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.65
Altman-Z 5.58
ROIC/WACC1.29
WACC8.38%
EXENS.PA Yearly LT Debt VS Equity VS FCFEXENS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.46 indicates that EXENS has no problem at all paying its short term obligations.
  • EXENS's Current ratio of 2.46 is amongst the best of the industry. EXENS outperforms 89.83% of its industry peers.
  • EXENS has a Quick Ratio of 1.54. This is a normal value and indicates that EXENS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of EXENS (1.54) is better than 81.36% of its industry peers.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 1.54
EXENS.PA Yearly Current Assets VS Current LiabilitesEXENS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. EXENS.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 15.07% over the past year.
  • EXENS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 337.95% yearly.
  • EXENS shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.10%.
  • Measured over the past years, EXENS shows a very strong growth in Revenue. The Revenue has been growing by 32.61% on average per year.
EPS 1Y (TTM)15.07%
EPS 3Y337.95%
EPS 5YN/A
EPS Q2Q%-65.88%
Revenue 1Y (TTM)22.1%
Revenue growth 3Y32.61%
Revenue growth 5YN/A
Sales Q2Q%23.97%

3.2 Future

  • Based on estimates for the next years, EXENS will show a very strong growth in Earnings Per Share. The EPS will grow by 20.84% on average per year.
  • The Revenue is expected to grow by 13.02% on average over the next years. This is quite good.
EPS Next Y30.89%
EPS Next 2Y24.11%
EPS Next 3Y22.67%
EPS Next 5Y20.84%
Revenue Next Year15.7%
Revenue Next 2Y14.64%
Revenue Next 3Y14.12%
Revenue Next 5Y13.02%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EXENS.PA Yearly Revenue VS EstimatesEXENS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
EXENS.PA Yearly EPS VS EstimatesEXENS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

3

4. EXENS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 74.82 indicates a quite expensive valuation of EXENS.
  • Compared to the rest of the industry, the Price/Earnings ratio of EXENS is on the same level as its industry peers.
  • The average S&P500 Price/Earnings ratio is at 27.18. EXENS is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 32.30 indicates a quite expensive valuation of EXENS.
  • The rest of the industry has a similar Price/Forward Earnings ratio as EXENS.
  • EXENS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 37.96, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 74.82
Fwd PE 32.3
EXENS.PA Price Earnings VS Forward Price EarningsEXENS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXENS is on the same level as its industry peers.
  • EXENS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 55.9
EV/EBITDA 22.59
EXENS.PA Per share dataEXENS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • EXENS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as EXENS's earnings are expected to grow with 22.67% in the coming years.
PEG (NY)2.42
PEG (5Y)N/A
EPS Next 2Y24.11%
EPS Next 3Y22.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. EXENS.PA Dividend Analysis

5.1 Amount

  • EXENS has a yearly dividend return of 0.47%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.69, EXENS has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.47, EXENS pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.47%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
EXENS.PA Yearly Dividends per shareEXENS.PA Yearly Dividends per shareYearly Dividends per share 2025 0.02 0.04 0.06 0.08

5.3 Sustainability

  • EXENS pays out 11.89% of its income as dividend. This is a sustainable payout ratio.
DP11.89%
EPS Next 2Y24.11%
EPS Next 3Y22.67%
EXENS.PA Yearly Income VS Free CF VS DividendEXENS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 2025 0 50M -50M -100M
EXENS.PA Dividend Payout.EXENS.PA Dividend Payout, showing the Payout Ratio.EXENS.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EXENS.PA Fundamentals: All Metrics, Ratios and Statistics

EXOSENS SAS

EPA:EXENS (4/13/2026, 7:00:00 PM)

62.85

+1.95 (+3.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)02-23
Earnings (Next)04-27
Inst Owners42.48%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner ChangeN/A
Market Cap3.20B
Revenue(TTM)468.19M
Net Income(TTM)42.72M
Analysts80
Price Target65.31 (3.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.47%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP11.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19.64%
PT rev (3m)28.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.1%
EPS NY rev (3m)4.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.92%
Valuation
Industry RankSector Rank
PE 74.82
Fwd PE 32.3
P/S 6.84
P/FCF 55.9
P/OCF 29.82
P/B 7.18
P/tB N/A
EV/EBITDA 22.59
EPS(TTM)0.84
EY1.34%
EPS(NY)1.95
Fwd EY3.1%
FCF(TTM)1.12
FCFY1.79%
OCF(TTM)2.11
OCFY3.35%
SpS9.19
BVpS8.75
TBVpS-0.26
PEG (NY)2.42
PEG (5Y)N/A
Graham Number12.86
Profitability
Industry RankSector Rank
ROA 4.86%
ROE 9.58%
ROCE 13.98%
ROIC 10.78%
ROICexc 11.66%
ROICexgc 33.27%
OM 22.85%
PM (TTM) 9.12%
GM 74.69%
FCFM 12.23%
ROA(3y)3.81%
ROA(5y)-3.76%
ROE(3y)8.68%
ROE(5y)-10.88%
ROIC(3y)8.65%
ROIC(5y)N/A
ROICexc(3y)9.5%
ROICexc(5y)N/A
ROICexgc(3y)28.7%
ROICexgc(5y)N/A
ROCE(3y)11.22%
ROCE(5y)N/A
ROICexgc growth 3Y18.32%
ROICexgc growth 5YN/A
ROICexc growth 3Y31.15%
ROICexc growth 5YN/A
OM growth 3Y16.35%
OM growth 5YN/A
PM growth 3Y17.77%
PM growth 5YN/A
GM growth 3Y1.11%
GM growth 5YN/A
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 4.65
Debt/EBITDA 1.79
Cap/Depr 126.69%
Cap/Sales 10.7%
Interest Coverage 250
Cash Conversion 73.27%
Profit Quality 134.09%
Current Ratio 2.46
Quick Ratio 1.54
Altman-Z 5.58
F-Score8
WACC8.38%
ROIC/WACC1.29
Cap/Depr(3y)114.05%
Cap/Depr(5y)122.34%
Cap/Sales(3y)10.57%
Cap/Sales(5y)10.87%
Profit Quality(3y)143.91%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.07%
EPS 3Y337.95%
EPS 5YN/A
EPS Q2Q%-65.88%
EPS Next Y30.89%
EPS Next 2Y24.11%
EPS Next 3Y22.67%
EPS Next 5Y20.84%
Revenue 1Y (TTM)22.1%
Revenue growth 3Y32.61%
Revenue growth 5YN/A
Sales Q2Q%23.97%
Revenue Next Year15.7%
Revenue Next 2Y14.64%
Revenue Next 3Y14.12%
Revenue Next 5Y13.02%
EBIT growth 1Y42.08%
EBIT growth 3Y54.29%
EBIT growth 5YN/A
EBIT Next Year53.65%
EBIT Next 3Y27.47%
EBIT Next 5Y22.97%
FCF growth 1Y-2.54%
FCF growth 3Y30.65%
FCF growth 5YN/A
OCF growth 1Y8.74%
OCF growth 3Y31.25%
OCF growth 5YN/A

EXOSENS SAS / EXENS.PA Fundamental Analysis FAQ

What is the fundamental rating for EXENS stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXENS.PA.


Can you provide the valuation status for EXOSENS SAS?

ChartMill assigns a valuation rating of 3 / 10 to EXOSENS SAS (EXENS.PA). This can be considered as Overvalued.


What is the profitability of EXENS stock?

EXOSENS SAS (EXENS.PA) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for EXENS stock?

The Price/Earnings (PE) ratio for EXOSENS SAS (EXENS.PA) is 74.82 and the Price/Book (PB) ratio is 7.18.


Can you provide the dividend sustainability for EXENS stock?

The dividend rating of EXOSENS SAS (EXENS.PA) is 2 / 10 and the dividend payout ratio is 11.89%.